Processing math: 100%
Research article Special Issues

Dynamics of drug on-drug off models with mutations in morbidostat — Dedicated to the seventieth birthday of Professor Gail Wolkowicz

  • The morbidostat is a bacteria culture device that progressively increases antibiotic drug concentration. It is used to study the evolutionary pathway. In this article, we construct mathematical models for the morbidostat. First we consider the case of no mutations, we study limiting systems and obtain criteria for the large time behavior of the solutions. From the theoretical results and numerical simulations, we conclude that there are two competitive exclusion states of either wild type or mutant type as the threshold parameter U varies. There are three cases, wild type bacteria excludes all mutants; a mutant dominates in the competition; oscillation between the above two states.

    Next we study the systems of forward mutations and forward-backward mutations. Then we apply a result of pertubation for globally stable state.

    Citation: Ziran Cheng, Sze-Bi Hsu. Dynamics of drug on-drug off models with mutations in morbidostat — Dedicated to the seventieth birthday of Professor Gail Wolkowicz[J]. AIMS Mathematics, 2023, 8(9): 20815-20840. doi: 10.3934/math.20231061

    Related Papers:

    [1] Dong-Mei Li, Bing Chai . A dynamic model of hepatitis B virus with drug-resistant treatment. AIMS Mathematics, 2020, 5(5): 4734-4753. doi: 10.3934/math.2020303
    [2] Komal Bansal, Trilok Mathur, Narinderjit Singh Sawaran Singh, Shivi Agarwal . Analysis of illegal drug transmission model using fractional delay differential equations. AIMS Mathematics, 2022, 7(10): 18173-18193. doi: 10.3934/math.20221000
    [3] Kasbawati, Mariani, Nur Erawaty, Naimah Aris . A mathematical study of effects of delays arising from the interaction of anti-drug antibody and therapeutic protein in the immune response system. AIMS Mathematics, 2020, 5(6): 7191-7213. doi: 10.3934/math.2020460
    [4] Sara J Hamis, Fiona R Macfarlane . A single-cell mathematical model of SARS-CoV-2 induced pyroptosis and the effects of anti-inflammatory intervention. AIMS Mathematics, 2021, 6(6): 6050-6086. doi: 10.3934/math.2021356
    [5] Yaw Chang, Wei Feng, Michael Freeze, Xin Lu, Charles Smith . Elimination, permanence, and exclusion in a competition model under Allee effects. AIMS Mathematics, 2023, 8(4): 7787-7805. doi: 10.3934/math.2023391
    [6] Yasir Nadeem Anjam, Asma Arshad, Rubayyi T. Alqahtani, Muhammad Arshad . Unveiling the dynamics of drug transmission: A fractal-fractional approach integrating criminal law perspectives. AIMS Mathematics, 2024, 9(5): 13102-13128. doi: 10.3934/math.2024640
    [7] Hongyan Wang, Shaoping Jiang, Yudie Hu, Supaporn Lonapalawong . Analysis of drug-resistant tuberculosis in a two-patch environment using Caputo fractional-order modeling. AIMS Mathematics, 2024, 9(11): 32696-32733. doi: 10.3934/math.20241565
    [8] Biwen Li, Qiaoping Huang . Synchronization issue of uncertain time-delay systems based on flexible impulsive control. AIMS Mathematics, 2024, 9(10): 26538-26556. doi: 10.3934/math.20241291
    [9] Ahmed M. Elaiw, Amani S. Alsulami, Aatef D. Hobiny . Global properties of delayed models for SARS-CoV-2 infection mediated by ACE2 receptor with humoral immunity. AIMS Mathematics, 2024, 9(1): 1046-1087. doi: 10.3934/math.2024052
    [10] Mansoor H. Alshehri . Computational study on encapsulation of 5-fluorouracil drug in nanotubes. AIMS Mathematics, 2022, 7(9): 16975-16985. doi: 10.3934/math.2022932
  • The morbidostat is a bacteria culture device that progressively increases antibiotic drug concentration. It is used to study the evolutionary pathway. In this article, we construct mathematical models for the morbidostat. First we consider the case of no mutations, we study limiting systems and obtain criteria for the large time behavior of the solutions. From the theoretical results and numerical simulations, we conclude that there are two competitive exclusion states of either wild type or mutant type as the threshold parameter U varies. There are three cases, wild type bacteria excludes all mutants; a mutant dominates in the competition; oscillation between the above two states.

    Next we study the systems of forward mutations and forward-backward mutations. Then we apply a result of pertubation for globally stable state.



    Antibiotic drug resistance is a global health problem [9]. Five years after the clinical application of penicillin, staphylococcus aureus with penicillin resistance [8] was found in humans, which caused penicillin to fail in some patients. These years, human beings may face the dilemma of infecting multiple drug-resistant bacteria (commonly known as superbugs) without any help of antibiotics because of the antibiotic drug resistance.

    In [10,11] the authors presented a devices for building and operating an automated fluid system for continuous culture called "morbidostat" (See Figure 1.1). The morbidostat is used to study evolution of mircobial drug resistance in real time, It constantly measure the growth rates of evoluting mircobial populations inside culture in order to maintain a constant drug-induced inhibition. The growth rate measurements are done by using an optical detection system. Similar to chemostat rate D lower than the maximal growth rate of population in morbidostat. In contrast to a chemostat in which the bacterial growth in inherently the cell density is kept low such that the population in not nutrient limited, its growth rate is also controlled by externally adjusting drug concentration.

    Figure 1.  A schematic of morbidostat.

    In this work, we follow the same mathematical model of morbidostat in [5,6]. When the total population of all bacteria are less than a threshold value U, there is no drug injection into the morbidostat and dPdt=DP. However if the total population of all bacteria reaches over the threshold value U, there will be continuous drug injection into morbidostat. The growth rate of species i will be gi(S)fi(P) where S is the concentration of nutrient, gi(S) takes the form of Holling type Ⅱ gi(S)=miSai+S and P is the concentration of drug, the inhibition fi(P) takes the form of Hill function fi(P)=11+(PKi)L and dPdt=D(P(0)P).

    Remark: We note that in [5,6], we assume

    f0(P)g0(S)f1(P)g1(S)fn(P)gn(S)(H)

    i.e, the n-th mutant has largest growth rate.

    In [6] we consider periodic resetting for nutrient and drug; while in [5] we consider drug on-drug off mechanism.

    In this paper we relax the assumption (H) with drug on-drug off dynamics in the morbidostat.

    In this work, we analyze the transition between the population of wild type u and those of mutant vi (i=1.2,,n). Consider the drug on-drug off model with forward mutations(see Figure 1.2) and forward-backward mutations(see Figure 1.3).

    Figure 2.  Forward mutations between species.
    Figure 3.  Forward-backward mutations between species.

    The growth dynamics with the nutrient substrate S in a chemostat under the influence of the drug inhibitor P with forward mutations and forward-backward mutations are given by (1) and (2) respectively:

    {dSdt=(S(0)S)D1γg0(S)f0(P)u1γni=1gi(S)fi(P)vidudt=(g0(S)f0(P)D)uq0udvidt=(gi(S)fi(P)D)vi+qi1vi1qividvndt=(gn(S)fn(P)D)vn+qn1vn1dPdt={DP, if u+nj=1vj<U(P(0)P)D, if u+nj=1vjU (1)
    {dSdt=(S(0)S)D1γg0(S)f0(P)u1γni=1gi(S)fi(P)vidudt=(g0(S)f0(P)D)uq0u+~q0v1dvidt=(gi(S)fi(P)D)vi+qi1vi1qivi~qi1vi+~qivi+1dvndt=(gn(S)fn(P)D)vn+qn1vn1~qn1vndPdt={DP, if u+nj=1vj<U(P(0)P)D, if u+nj=1vjU (2)

    where i=1,2,3,,n1. Let v0=u and vi are the volume densities of the wild type and mutant populations, respectively. γ denotes the yield constant, reflecting the conversion of nutrient to bacteria. S is the concentration of nutrient, while S(0) is the input concentration of nutrient. D is the dilution rate. g0(S) and gi(S) are the growth rates of the wild type and mutants, which satisfy gi(0)=0, gi(S)>0 for i=0,1,2,,n. It implies that bacteria grows only when there has nutrient substrate in the device, and a higher concentration of nutrient leads to the bacteria's higher growth rates. Here we consider the important special case gi(S)=miSai+S. qi denotes the forward mutation from vi to vi+1, and ~qi is the backward mutation from vi+1 to vi. qi and ~qi are small positive quantities. Besides, the drug inhibitions for vi are described by fi(P) for i=0,1,2,,n. It is easy to know, the higher concentration of drug leads to a stronger inhibition to the growth of bacteria. Based on the fact that mutants always have stronger resistances to the inhibitor than wild-type, and the i-th mutant vi has stronger resistances than the (i1)-th mutant vi1. So we assume

    fi(0)=1,fi(P)<0,f0(P)f1(P)fn(P)(H1)

    for i=0,1,2,,n.

    Let gi(λi)=D, i.e. λi=ai(miD1). We also assume that:

    λ0<λ1<<λn<S(0)(H2)

    which implies the wild type u which has smallest break-even concentration, is the most superior species than the mutants vi in the absence of drug inhibition [1].

    The rest of this paper is organized as follows. In Section 2 we study the dynamics of drug on-drug off models with no mutations, In Section 3 we study the dynamics of drug on-drug off models with forward mutations. In Section 4 we study the dynamics of drug on-drug off models with forward-backward mutations. Section 5 is a section of numerical simulations for various threshold parameters U. Section 6 is the discussion section.

    Without loss of generality by scaling, we assume the yield constant, γ=1.

    Lemma 2.1. (Conservation Property) S(t)+ni=0vi(t)S(0) as t.

    Proof. Let M(t)=S(t)+ni=0vi(t).

    Adding the first n+2 equations of (1) and (2), yields

    dM(t)dt=(S(0)S)DDni=0vi=(S(0)M(t))D

    So M(t)=S(t)+ni=0vi(t)S(0) as t.

    For simplicity in (1) we assume that qi=0 for all i=0,1,2,,n. Let u=v0, the system (1) becomes

    {dSdt=(S(0)S)Dni=0gi(S)fi(P)vidvidt=(gi(S)fi(P)D)vi,i=0,1,2,,ndPdt={DP, if nj=0vj<U(P(0)P)D, if nj=0vjU (3)
    S(0)>0,vi(0)>0,i=0,1,,n,P(0)>0.

    Next we state two theorems which will be used in Section 2.1 below.

    Theorem A (Competitive exclusion in simple chemostat) ([1] p. 30 or p. 35)

    Consider the simple chemostat equation

    dSdt=(S(0)S)Dni=0gi(S)vidvidt=(gi(S)D)vi,i=0,1,2,,n,

    with S(0)0 and vi(0)>0. Let (H2) hold. Then

    limtS(t)=λ0limtv0(t)=v0=S(0)λ0limtvi(t)=0,i=1,2,,n.

    Consider two systems of ordinary differential equations of the form

    z=Az,y=f(y,z) (F.1)

    and

    x=f(x,0) (F.2)

    where

    zRm,(y,z)DRn×RmxΩ={x|(x,0)D}Rn.

    We assume A is an m×m matrix, f is continuous differentiable, D is positively invariant for (F.1) and (F.2) is dissipative. Let (B1)-(B5) be additional hypothesis:

    (B1) All of eigenvalues of A have negative real parts.

    (B2) Equation (F.2) has finite number of rest points in Ω, each of which is hyperbolic ([2], p. 88) for (F.2). Denote these rest points by x1,,xp.

    (B3) The dimension of the stable manifold {([2], p. 88)} is n for 1ir, and the dimension of the stable manifold of xj is less than n for j=r+1,,p. In symbols, dim(M+(xj))=n,i=1,,r; dim(M+(xj))<n for j=r+1,,p.

    (B4) Ω=pi=1M+(xj).

    (B5) Equation (F.2) does not possess a cycle of rest points.

    Theorem B (A convergence theorem)([1], p. 294)

    Let (B1)-(B5) hold and (y(t),z(t)) be a solution of (F.1). Then, for some i,

    limt(y(t),z(t))=(xi,0).

    For the solution of the system (3), we discuss the following three cases:

    Case 1 : ni=0vi(t)<U for all t>t0>0 for some t0>0. Then we have

    dPdt=DP, fortt0

    it is obvious that

    P(t)0  as  t

    Let

    Σ1(t)=S(0)S(t)ni=0vi(t)Σ2(t)=P(t).

    Then by Lemma 2.1, we have

    Σ1(t)=DΣ1(t)Σ2(t)=DΣ2(t)

    and Σ1(t)0 and Σ2(t)0 as t. Rewrite the system (3) with dPdt=DP as

    Σ1(t)=DΣ1(t)Σ2(t)=DΣ2(t)vi(t)=(gi(S(0)Σ1(t)ni=0vi(t))fi(Σ2(t))D)vi,i=0,1,2,,n. (2.1)
    D={(Σ1,Σ2,v0,,vn):vi>0,i=0,1,,n,ni=0vi+Σ1S(0),Σ2>0}.

    The system corresponding to (F.2) in Theorem B is

    vi(t)=(gi(S(0)ni=0vi(t))fi(0)D)vi=(gi(S(0)ni=0vi(t))D)vi,i=0,1,2,,n. (2.2)

    Apply Theorem B with A=diag(D,D),m=2 and

    Ω={(v0,v1,,vn):vi>0,ni=1viS(0)}.

    Under the hypothesis (H2), we apply Theorem A and obtain a result of global stability,

    limtv0(t)=v0=S(0)λ0limtvi(t)=0,i=1,2,,n.

    Now we verify the hypothesis (B1)-(B5) holds for the systems (2.1) and (2.2). Obviously the 2×2 matrix A satisfies hypothesis (B1). For hypothesises (B2), (B3), (B4), equation (2.2) has finite number of rest points in Ω, namely, O=(0,0,,0), E0=(v0,0,,0), Ei=(0,,vi,,0), vi=S(0)λi,i=1,2,,n. dim(M+(E0))=n+1, dim(M+(Ei))=n(i1),i=1,2,,n. To verify the cyclic condition (B5), we note that from (H2) Ej is chained to Ei, EjEi,j>i,i,j=0,1,2,,n if and only if λj<λi and EiO for all i=1,2,,n. Suppose there is a cycle in Ω, Ek(1)Ek(2)Ek(1) then it follows that λk(1)<λk(2)<<λk(1) which is obviously a contradiction to (H2)

    Case 2 : ni=0vi(t)U for all t>t0>0 for some t00. Then we have

    dPdt=D(P(0)P)

    we have

    P(t)P(0) as t.

    Let

    Σ1(t)=S(0)S(t)ni=0vi(t)Σ2(t)=P(0)P(t)

    Then we have

    Σ1(t)=DΣ1(t)Σ2(t)=DΣ2(t)

    and Σ1(t)0 and Σ2(t)0 as t. Rewrite the system (3) with dPdt=(P(0)P),

    Σ1(t)=DΣ1(t)Σ2(t)=DΣ2(t)vi(t)=(gi(S(0)Σ1(t)ni=0vi(t))fi(P(0)Σ2(t)))vi,i=0,1,2,,n. (2.3)
    D={(Σ1,Σ2,v0,,vn):vi>0,i=0,,n.ni=0vi+Σ1S(0),Σ2>0}.

    The system corresponding to (F.2) in Theorem B is

    vi(t)=(gi(S(0)ni=0vi(t))fi(P(0))D)vi,i=0,1,2,,n. (2.4)

    We may verify the hypothesises (B1)-(B5) as in the Case 1.

    If mifi(P(0))D, then it is easy to show limtvi(t)=0. Thus we assume that

      mifi(P(0))>D,  i=0,1,2,,n(H3)

    Replace mi in gi(S) by mifi(P(0)), we have a new simple chemostat equation.

    Let

    ^λk=min0inˆλi, where ^λi=aimifi(P(0))D1,

    then

    S(t)^λkvk(t)^vk=S(0)^λkvi(t)0,ik (2.5)

    as t or

    limt(v0(t),v1(t),,vn(t))=(0,,S(0)^λk,,0)

    Case 3 : ni=0vi<U at some sequence {tk}, tk and ni=0viU at some other sequence {tl}, tl,k=1.2., l=1,2,, kl, ni=0vi oscillates around U.

    Lemma 2.2. Let vi,i=0,,n be the solution of system (2.4). Let (H1), (H2), (H3) hold, then ^vk<v0.

    Proof. Since

    ^λk=akmkfk(P(0))D1 and λk=akmkD1

    and 0<fi(P(0))<1, then ^λk>λk.

    Obviously, we obtain

    ^vk=S(0)^λk<S(0)λk<S(0)λ0=v0

    Hence,

    ^vk<v0

    In the following Theorem 2.3 we shall give sufficient conditions for the Case 1, Case 2 and Case 3 for the solutions of the system (3).

    Theorem 2.3. Let (H1), (H2), (H3) hold and vi,i=0,1,,n be the solutions of the system (3), then

    (I) if U>v0, then there exists t0>0, such that for all tt0, ni=0vi(t)<U. From Case 1 in section 2.1, limtS(t)=λ0, limtu(t)=S(0)λ0, limt=→vi(t)=0, i=1,2,,n.

    (II) Let ^λl=max0inˆλi and ^vl=S(0)^λl<^vk. If U<^vl, then there exists t0>0, such that for all tt0, ni=0vi(t)U. From Case 2 in section 2.1, limtS(t)=^λk, limtvk(t)=^vk=S(0)^λk, limtvi(t)=0,ik,i=0,1,2,,n.

    (III) if ^vk<U<v0, then ni=0vi(tk)U for some {tk}, tk and ni=0vi(tl)<U for some other sequence {tl}, tl. This is Case 3 in section 2.1, ni=0vi(t) oscillates around U.

    Proof.

    1. We shall exclude the following two cases:

    (i) ni=0vi(t)U for all t>0.

    From Case 2 in section 2.1, we have vk^vk, vi0, where ik.

    So ni=0vi^vk<U as t. By Lemma 2.2 ni=1vi(t)^v0<v0<U a contradiction to ni=0vi(t)U for all t0.

    (ii) There exists ˆt>0, such that

    ni=0vi(ˆt)=U, and ddt(ni=0vi)|t=ˆt>0 (2.6)

    In this case, consider the system (2.1),

    we obtain that

    ddt(ni=0vi)|t=ˆt=ni=0(gi(S)fi(P)D)vini=0(gi(S)D)vi=ni=0(gi(S(0)vi)D)vi=ni=0(gi(S(0)vi)gi(λi))vini=0vi(ˆt)=U>v0=S(0)λ0

    It follows that S(0)ni=1vi(ˆt)=S(0)U<λ0<λ1<<λn,

    gi(S(0)ni=0vi(ˆt))<gi(λi) for all i=0,1,,n.

    Hence ddt(ni=0vi)|t=ˆt<0.

    This is a contradiction to (2.6).

    Hence, we exclude (i) and (ii). It follows that ni=0vi<U for tt0 for some t0>0.

    2. We shall exclude the following two cases:

    (i) ni=0vi(t)U for all t>0.

    In this case, we have v0v0, vi0, where ik.

    So ni=0viv0>U as t. Since U<^vl<^vk<v0, we obtain a contradiction to ni=0vi(t)U for all t>0

    (ii) There exists ˉt>0, such that

    ni=0vi(ˉt)=U, and ddt(ni=0vi)|t=ˉt<0 (2.7)

    In this case, we consider the system (3),

    we obtain that

    ddt(ni=0vi)|t=ˉt=ni=0(gi(S)fi(P)D)vini=0(gi(S)fi(P(0))D)vi=ni=0(gi(S(0)vi)fi(P(0))D)vi=ni=0(gi(S(0)vi)fi(P(0))gi(^λi)fi(P(0)))vi=ni=0(gi(S(0)vi)gi(^λi))fi(P(0))vi (2.8)

    Let

    ^λl=max0inˆλi, and ^vl=S(0)^λl<^vk

    When U^vl, ni=0vi(ˉt)=U^vl=S(0)^λl

    It follows that S(0)ni=0vi(ˉt)^λl>^λi, i=0,1,,n and il

    The monotonicity of gi(S) implies that gi(S(0)vi)gi(^λi), from (2.8)

    ddt(ni=0vi)|t=ˉt0

    This is a contradiction to (2.7)

    Hence ni=0vi(t)U for all t large.

    3. Assume ˆvk<U<^v0, ni=0viU for all t>0.

    Then from (H3) and (2.6), vk^vk, vi0, where ik.

    So ni=0vi^vk<U as t, a contradiction to the assumption ni=0viU for all t large.

    Suppose ni=0vi<U for t large.

    Then from (H2) v0v0, vi0, i=1,2,,n, as t.

    So ni=0viv0>U as t, a contradiction.

    Hence ni=0vi oscillates around U.

    Remark 2.4. When ^vlU<^vk, from the numerical studies in section 5, we conjecture that the conclusion in (Ⅱ) in Theorem 2.3 holds, i.e. limtS(t)=^λk, limt^vk(t)=^vk=S(0)^λk, limtvi(t)=0 for ik, i=0,1,,n.

    Remark 2.5. When the threshold value U satisfies ˆvk<U<ˆv0, we conjecture that the competitive exclusion principle holds. In this case, we conjecture that there exist a bifurcation point U such that for ˆvk<U<U, species vk wins the competition; for U<U<v0 the wild type species u:=v0 wins the competition. We note that from (Ⅲ) of Theorem 2.3 for ˆvk<U<ˆv0, ni=0vi oscillates around U. Thus the solution of the system (3) will not tend to equilibrium E0=(λ0,ˆv0,0,,0) or E1=(ˆλ0,0,,0,ˆvk,0,,0). See Figure 5.3 (a), 5.3 (b), 5.3 (c) and Figure 5.4(a), 5.4(b), 5.4(c) in Section 5.

    Consider the following drug on-drug off model with forward mutation:

    {dSdt=(S(0)S)Dni=0gi(S)fi(P)vidudt=(g0(S)f0(P)D)uq0udvidt=(gi(S)fi(P)D)vi+qi1vi1qivi,i=1,,n1dvndt=(gn(S)fn(P)D)vn+qn1vn1dPdt={DP, if nj=0vj<U(P(0)P)D, if nj=0vjU (1)

    As we did in Section 2, we discuss three cases.

    Case 1 : ni=0vi(t)<U for all t>t0 for some t0>0. Then we have

    dPdt=DP.

    It is obvious that

    P(t)0 as t

    As we did in case 1 in Section 2.1, it suffices to consider the limiting system of (1)

    {S=S(0)ni=0vidv0dt=(g0(S)Dq0)v0dvidt=(gi(S)Dqi)vi+qi1vi1, i=1,2,,n1dvndt=(gn(S)D)vn+qn1vn1 (3.1)

    Theorem 3.1. Let q=(q0,q1,,qn), then (3.1) has a unique positive equilibrium E(q)=(v0(q),,vn(q)) satisfying

    {S=g10(D+q0)(gi(S)Dqi)vi+qi1vi1=0, i=1,2,,n1(gn(S)D)vn+qn1vn1=0ni=0gi(S)vi=(S(0)S)D (3.2)

    Proof. Consider the first equation of (3.1) :

    dv0dt=(g0(S)Dq0)v0.

    Then the positive equilibrium, v0=v0(q)>0, satisfies

    g0(S)Dq0=0.

    The monotocity of g0(S) implies that S=g10(D+q0) is unique.

    Since q0 is close to 0, we have S is close to g10(D)=λ0.

    Let S=λ0+ϵ, ϵ>0 is small enough.

    From (H2), it follows that gi(S)=gi(λ0+ϵ)<gi(λi)=D, i=1,2,,n1.

    Then we have for i=1,2,,n1,

    gi(S)Dqi<0 and gn(S)D<0 (3.3)

    Consider the n+1 equations in (3.2), we denote them in the form of Ax=y as following,

    [q0g1(S)Dq10000q1g2(S)Dq20000q200000qn1gn(S)Dg0(S)g1(S)g2(S)gn1(S)gn(S)][v0v1v2vn1vn]=[0000D(S(0)S)]

    Let A(0) =

    [q0g1(S)Dq100000q1g2(S)Dq200000q2000000qn1gn(S)D0g0(S)g1(S)g2(S)gn1(S)gn(S)D(S(0)S)]

    We apply the following elementary transformations on A(0).

    (Step 1) Consider the (n+1)-th row in A(0), multiplying g0(S)q0 to 1st row and subtracting it from (n+1)-th row, and we have

    A(1)=

    [q0g1(S)Dq100000q1g2(S)Dq200000q2000000qn1gn(S)D00m1g2(S)gn1(S)gn(S)D(S(0)S)]

    where m1=g1(S)g0(S)q0(g1(S)Dq1)

    Since g1(S)>0, g0(S)>0, q0>0, we have m1>0.

    After n elementary transformations, we get an upper triangular matrix

    A(n)=

    [q0g1(S)Dq100000q1g2(S)Dq200000q2000000qn1gn(S)D0000mnD(S(0)S)] (3.4)

    So the solution (v0,v1,v2,,vn) exists and is unique.

    By mathematical induction, we can show that, mn in A(n) is positive.

    From (3.4), we have

    mnvn=D(S(0)S)

    and it follows that vn>0

    From (3.2), we obtain

    vn1=(gn(S)D)vnqn1>0.

    For each 1in1,

    vivi1=qi1gi(S)+D+qi>0.

    Hence vi>0 for all 0in.

    and the equilibrium E(q)=(v0(q),v1(q),v2(q),,vn(q)) is positive.

    Since q0, E(q) is closed to E0, so we use the following perturbation theory to discuss the local and global stability of E(q).

    Theorem 3.2. [4] Let A,BCn×n, with A simple. If A has eigenvalues λ1,λ2,,λn and μ is an eigenvalue of A+B, and if for a matrix norm induced by an absolute vector norm v, we have r=BAv, then μ lies in at least one of the disks z:|zλj|r, j=1,2,,n, of the complex z-plane.

    Theorem 3.3. [7] Assume that (x0,λ0)U×Λ, x0IntU, f(x0,λ0)=0, all eigenvalues of Dxf(x0,λ0) have negative real part, and x0 is globally attracting for solutions of x=f(x,λ) with λ=λ0. If there exists a compact set DU such that for each λΛ and each zU, x(t,z,λ)D for all large t, then there exists ϵ>0, and a unique point ^x(λ)U for λBΛ(λ0,ϵ) such that f(ˆx(λ),λ)=0 and x(t,z,λ)ˆx(λ) as t for all zU.

    Theorem 3.4. E(q) is locally stable.

    Proof. From (2.2) in Section 2, E0 is a stable equilibrium where E0=(v0,0,,0),v0=S(0)λ0. The Jacobi matrix of system (2.2) evaluated at E0, is

    J(E0)=[v0g0(λ0)v0g0(λ0)v0g0(λ0)0g1(λ0)D00000gn(λ0)D] (3.5)

    The eigenvalues μ0,μ2,,μn+1 of J(E0) are μ0=v0g0(λ0)<0,μ1=g1(λ0)D<0,,μn=gn(λ0)D<0.

    From (3.2), we have the Jacobi matrix of system (3.1) evaluated at E(q),

    J(E(q))=

    [g0(S)v0g0(S)v0g1(S)v1+q0(g1(S)Dq1)g1(S)v1g1(S)v1g2(S)v2g2(S)v2+q1(g2(S)Dq2)g2(S)v2g2(S)v2gn(S)vngn(S)vngn(S)+qn1(gn(S)D)+(gn(S))vn] (3.6)

    Since qi is sufficiently small,

    we have gi(S)gi(λ0) and gi(S)gi(λ0).

    Let J(E(q))=J(E0)+B, then |B|0.

    From Theorem 3.2, the eigenvalues of J(E(q)) lies in at least one of the disks z:|zμi|ϵ,i=0,1,,n (ϵ is small enough).

    Since μi<0 for all i=0,1,,n, all eigenvalues of J(E(q)) have negative real part.

    Hence E(q) is locally stable.

    Theorem 3.5. E(q) is globally stable.

    Proof. Write (3.2) as dxdt=f(x,q), when x=(S,u,v1,,vn) and q=(q0,q1,,qn1).

    Take U=R+Bϵ(E0), and Λ(q)=[0,δ]n1.

    when q=0, i.e. all the qi=0 for each 0in, f(E0,0)=0, and Dxf(E0,0) has all negative eigenvalues.

    Take D=[0,S(0)]n+2, then D is compact.

    when qi0, and x=E(q), we have f(E(q),q)=0.

    By Theorem 3.3, x(t,z,q)E(q) as t for all zU.

    This concludes that E(q) is globally stable.

    Next we discuss Case 2.

    Case 2 : ni=0vi(t)U for all t>t0 for some t0>0.

    Then

    dPdt=D(P(0)P),

    and hence

    P(t)P(0) as t.

    As we did in Case 2 in Section 2.1, it suffice to consider the limiting system of (1)

    {S=S(0)ni=0vidv0dt=(g0(S)f0(P(0))Dq0)v0dvidt=(gi(S)fi(P(0))Dqi)vi+qi1vi1dvndt=(gn(S)fn(P(0))D)vn+qn1vn1 (3.7)

    We shall study (3.7) by using the same method for the system (2.4) in section 2.1,

    Suppose (H3) holds, let

    ^λi=aimifi(P(0))D1>0, i=0,1,2,,n.

    Theorem 3.6.

    1. System (3.7) has an equilibrium E=(v0,,vn).

    (i) If ^λ0=min0inˆλi, then vi>0 for all i=0,1,,n. Write E=(¯v0,¯v1,,¯vn) satisfying

    {ˉS=g10(D+q0f0(P(0)))(gi(ˉS)fi(P(0))Dqi)¯vi+qi1ˉvi1=0,i=1,,n1(gn(ˉS)fn(P(0))D)¯vn+qn1ˉvn1=0ni=0gi(ˉS)fi(P(0))¯vi=(S(0)ˉS)D (3.8)

    (ii) If ^λk=min0inˆλi for some k, 0<k<n, then vi=0 for i=0,1,,k1 and vj>0 for kjn. Write E=(0,,~vk,,~vn) satisfying

    {˜S=g1k(D+qkfk(P(0)))~vi=0 (0i<k)(gi(˜S)fi(P(0))Dqi)~vi+qi1~vi1=0 (kin1)(gn(˜S)fn(P(0))D)~vn+qn1~vn1=0ni=0gi(˜S)fi(P(0))~vi=(S(0)˜S)D (3.9)

    (iii) If ^λn=min0inˆλi, then vi=0 for all i=0,1,,n1 and vn>0. Write E=(0,0,,0,vn), vn=S(0)ˆλn.

    2. For the system (3.7), E is global stable. \end{enumerate}

    Proof.

    1.

    (i) Since ˆλ0<ˆλi,i=1,2,,n, replacing gi(S) by fi(P(0))gi(S) in Theorem 3.1, we complete the proof of (i).

    (ii) Consider the steady state of the first equation in (3.7),

    (g0(S)f0(P(0))Dq0)v0=0.

    Claim: v0 = 0

    if not, v0>0 then g0(S)f0(P(0))Dq0=0. Since the mutation rate qi,i=0,1,,n are sufficiently small, g0(S)g0(^λk).

    g0(S)f0(P(0))Dq0g0(^λk)f0(P(0))Dq0<g0(^λ0)f0(P(0))Dq0=q0<0.

    This leads to a contradiction g0(S)f0(P(0))Dq0=0. Hence we have v0=0.

    Similarly from the steady state equation of (3.7)

    (gi(S)fi(P(0))Dqi)vi+qi1v(i1)=0,i=1,2,,k1,

    we obtain vi=0,i=1,2,,k1. Thus E=(0,,0,ˆvk,,ˆvn) satisfies (3.9).

    Consider the nk+1 equations in (3.9), we denote them in the form of Ax=y as following,

    [qkgk+1(˜S)fk+1(P(0))Dqk+1000qk+1gk+1(˜S)fk+2(P(0))Dqk+2000qn1gn(˜S)fn(P(0))Dgk(˜S)fk(P(0))gk+1(˜S)fk+1(P(0))gn1(˜S)fn1(P(0))gn(˜S)fn(P(0))][~vk~vk+1~vn1~vn]=[000D(S(0)˜S)] (3.10)

    Since qk is close to 0, we have ˜S is close to g1k(Dfk(P(0)))=^λk.

    Let ˜S=^λk+ϵ, ϵ is small enough,

    From (H2), get gi(˜S)fi(P(0))=gi(^λk+ϵ)fi(P(0))<gi(^λi)fi(P(0))=D.

    It follows that gi(˜S)fi(P(0))Dqi<0, and gn(˜S)D<0.

    Use the same method as Theorem 3.1, we have ˜vi>0 when kin.

    (iii) Particularly, when ^λn=min0inˆλi,

    Let gn(S)fn(P(0))D=0, we can get S=^λn.

    Similarly, we can use mathematical induction as the second part of Theorem 3.6 to prove that vi=0 for all 0in1, and then vn=S(0)λn.

    2. Since qi is small enough and close to 0, E is close to E1.

    We can also use the perturbation theory (Theorem 3.2 and Theorem 3.3) to prove the local and global stability of E. The proof is similar to Theorem 3.4 and Theorem 3.5.

    Case 3 :

    If ni=0vi(tk)<U at some sequence {tk}, tk and ni=0vi(tl)U at some other sequence {tl}, tl, k=1.2., l=1,2,, kl, ni=0vi oscillates around U.

    From Lemma 2.1, we have S(t)+ni=0vi(t)S(0) as t.

    In case 1, S(t)S=g10(D+q0), which is close to λ0.

    So ni=0vi(t) is close to S(0)λ0 (=v0) as t.

    In case 2, SS=g1k(D+qk), which is approximately equal to ^λk, but a little greater than ^λk.

    So ni=0vi(t) is close to S(0)^λk (=^vk) as t.

    By the theory of perturbation, we can get the same relation between ni=0vi and U as Theorem 2.3 in Section 2.

    Theorem 3.7. Let (H1), (H2), (H3) hold, then

    (I) if U>v0, then there exists t0, such that for all tt0, ni=0vi(t)<U

    (II) Let ^λl=max0inˆλi and ^vl=S(0)^λl<^vk. If U<^vl, then there exists t0>0, such that for all tt0, ni=0vi(t)U.

    (III) if ^vk<U<v0, then ni=0vi(tk)U for some sequence {tk}, tk and ni=0vi(tl)<U for some other sequence {tl}, tl.

    Proof.

    (I) Assume U>v0, we shall exclude the following two cases.

    (i) ni=0vi(t)U for t>0. Then P(t)P(0) as t. Consider the limiting system (3.7). By perturbation method in Theorem 3.3 and the result in Case 2 of section 2.1, we have

    vk(t)vk+c1(q),vi(t)ci(q)

    where ik, c1(q) and ci(q) are small, q=(q1,,qn). Then

    ni=0vivk+c1(q)+i1ci(q)

    and it follows that

    ni=0vi(t)<vk+c1(q)+i1ci(q)<v0<U, for tlarge.

    This is a contradiction to the assumption (i):

    ni0vi(t)U for t0.

    (ii) There exists ˆt>0 such that

    ni=0vi(ˆt)=U and ddt(ni=0vi(t))|t=ˆt>0.

    From the system (1),

    ddt(vi)|t=ˆt=ni=0(gi(S)fi(P)D)vi(gi(S)D)vi=(gi(S(0)vi)D)=(gi(S(0)vi)gi(λi)),
    ni=0vi(ˆt)=U>v0=S(0)λ0.

    It follows that

    S(0)vi(ˆt)<λ0<λ1<<λn
    gi(S(0)ni=0vi(ˆt))<gi(λi),i=0,1,,n.

    Hence

    ddt(ni=0vi)|t=ˆt<0.

    This is a contradiction. Excluding (i) and (ii), we obtain ni=0vi<U for t large.

    (II) Assume U<ˆvl. Then ni=0vi(t)U for tt0. Applying the perturbation method and the method in Theorem 2.3 (Ⅱ), we finish the proof of (Ⅱ).

    (III) Assume vk<U<v0. Suppose ni=0viU for t large. Then by perturbation method in Theorem 3.3 and the results in Case 2 of section 2.1,

    vk(t)vk+c1(q),vi(t)ci(q),ik,
    vivk+c1(q)+ikci(q)<U,

    a contradiction.

    Suppose ni=0vi<U for t large. Then

    v0(t)v0+c0(q),vi(t)ci(q),i=1,2,,n as t.

    Hence viv0+c0(q)+ni=1ci(q)>U, a contradiction.

    Hence ni=0vi oscillates around U.

    Consider the model

    {dSdt=(S(0)S)Dni=0gi(S)fi(P)vidudt=(g0(S)f0(P)D)uq0u+~q0v1dvidt=(gi(S)fi(P)D)vi+qi1vi1qivi~qi1vi+~qivi+1,1in1dvndt=(gn(S)fn(P)D)vn+qn1vn1~qn1vndPdt={DP, if nj=0vj<U(P(0)P)D, if nj=0vjU (2)

    Lemma 4.1. ([3], p. 141) If y(t) has a finite limit as t and y(n) is bounded for tt0, then y(k)(t)0 as t for 0<k<n.

    In this section we only consider Case 1 and Case 2, i.e. we assume either U>v0 or U<ˆvl. Then the solutions of (2) are smooth.

    Lemma 4.2. In (2), if vm(t)0 as t for some m, 0mn, then we can get vk(t)0 as t, for all km and 0kn.That means all the species will go extinction as long as one of them goes extinction when time is long enough. Otherwise, all species coexists.

    Proof. We just prove the cases when 0<m<n, since m=0 and m=n are similar.

    Consider the model (2), we have

    dvmdt=(gm(S)fm(P)Dqm~qm1)vm+qm1vm1+~qmvm+1.
    d2vmdt2=(gm(S)fm(P)Dqm~qm1)vm+(gm(S)Sfm(P)+gm(S)fm(P)P)vm+qm1vm1+~qmvm+1 (4.1)

    From Lemma 2.1, we have

    S(t)+ni=0vi(t)S(0) as t, (4.2)

    and 0<SS(0) and 0<PP(0).

    From the first equation in (2),

    |S|S(0)D+max0jn{gj(S(0))}ni=1viS(0)D+MsS(0).

    For 1in1,

    |vi||(gi(S)fi(D)Dqi~qi1)vi|+qi1vi1+~qivi+1max{gi(S(0))+D+gi+~gi1,qi1,~gi}ni=0vi,

    from (4.2),

    ni=0viS(0),0<S<S(0),0<P<P(0),

    it is easy to see that |vi|, |P|DP(0), |S|, |fm(P)|, |gm(S)| are bounded.

    It follows from (4.1), we conclude that |d2vmdt2| is bounded.

    Since vm0 as t, and |d2vmdt2| is bounded.

    From Lemma 4.1, we have dvmdt0 as t.

    It implies that qm1vm1+~qmvm+10 as t, vm10, vm+10 as t.

    Hence vk0 as t for km.

    From Lemma 4.2, there are two cases: Either all the bacteria vi (0in) go extinction or all of them coexist. In the drug on-drug off model with forward-backward mutations, we get the next results.

    Theorem 4.3. Let the hypothesis (H1) and (H2) hold and vi (0in) be the solutions of system (2), then the species vi (0in) coexists.

    Proof. If all the species vi (i=0,1,,n) go extinction, then ni=0vi0<U as t.

    We have

    SS(0) and P0.

    Consider the second equation of the system (2):

    dudt=(g0(S(0))Dq0)u+~q0v1

    Since g0(S(0))D=g0(S(0))g0(λ0)>0 and qi, ~qi are sufficiently small.

    dudt>0 as t, which contradicts to u0 as t.

    Hence all the species vi (i=0,1,,n) coexist for t large in the system (2) with forward-backward mutation.

    Remark 4.4. We note that since the mutant rates ~qi are quite small, the most resistant vk whose ^λk=min0inˆλi, where ^λi=aimifi(P)D1 dominates the rest species.

    In this numerical simulation, we consider the case n=2 and verify the conjecture in Remark 2.4 and Remark 2.5.

    For simplicity, we assume S(0)=10, D=0.9 and

    gi(S)=miSai+S for i=0,1,,n

    where a0=2, a1=2, a2=3, m0=3, m1=2, m2=1.5.

    Since gi(λi)=D, we have λ00.86, λ12.44 and λ2=4.5.

    Hence v0=S(0)λ09.14.

    Let P(0)=10 and

    fi(P)=11+(PKi)L for i=0,1,2

    where L=1, K0=6, K1=15, K2=40.

    After calculations, we have ^λ0=8, ^λ1=6, ^λ2=9, Then ˆλ1=min(^λ0,^λ1,^λ2), ˆλ2=max(^λ0,^λ1,^λ2), and

    ^vk=^v1=4, and ^vl=^v2=1.

    Take U=3, then ^v2U<^v1.

    1. When there is no mutation, under the assumption (H3), (2.5), the mutant v2 survives, but the wide type v0 and the other mutant v1 go extinct. V:=2i=0vi(t)U for time t large, satisfying the conjecture in Remark 2.4.

    In Figure 5.1 (a), (b), (c) we verify the conjecture that if ˆvl<U<ˆvk then vk(t)ˆvk,vi0 for ik.

    Figure 51a.  Shows the prediction V:=ni=0vi>U for t large. The numerical data is U=3, ˆvl=1<U=3<ˆvk=4.
    Figure 51b.  Shows the prediction P(t)P(0) for t large, P(0)=10.
    Figure 51c.  Shows vk(t)ˆvk as t and vi(t)0,ik as t, where k=1, vk=v1=4.

    In the following Figure 5.2 and Figure 5.3, U satisfies ˆvk<U<v0. Thus the total population V=ni=0vi oscillates around U. We conjecture that there exists U between ˆvk and v0 such that species vk win the competition when ˆvk<U<U and species v0 (wild Type) win the competition when U<U<v0, For the numerical data is n=2, ˆvk=4, v0=9.14, we compute the value U, U5.846.

    Figure 52a.  V=2i=0vi is the total population of the bacteria. Since ˆvk=4<U=5.5<v0=9.14, from (III) of Theorem 2.3, V oscillates around U.
    Figure 52b.  The drug concentration P(t) oscillates between 0 and P(0)=10.
    Figure 52c.  The population v1 wins the competition however v1 oscillates, not tends to v1.
    Figure 53a.  The total population V oscillates around U=6.5.
    Figure 53b.  The drug concentration P(t) oscillates between 0 and P(0)=10.
    Figure 53c.  The population v0 wins the competition however v0 oscillates, not tends to v0, v0=9.14.

    2. Let U=5.5, ˆvk<U<U, ˆvk=4, U5.846 and the initial data (9.2,0.3,0.3,0.2) near equilibrium E0=(v0,0,0,0)=(9.14,0,0,0), then the trajectories of the system (3) are shown in Figure 5.2 (a), 5.2 (b), 5.2 (c).

    3. Let U=6.5, U<U<v0, U5.846, v0=9.14, and the initial data (6.2,0.2,4.3,0.3,9.5) near equilibrium E1=(0,v1,0,P(0))=(0,4,0,10), then the trajectories of the system (3) are shown in Figure 5.3 (a), 5.3 (b), and 5.3 (c).

    The authors would like to give their sincere thanks to the anonymous referee for his/her valuable suggestions to improvement of the paper. The second author's research is supported by MOST 111-2115-M-007-011.

    There is no conflict of interest.



    [1] H. L. Smith, P. E.Waltman, The theory of the chemostat, Cambridge University Press, Cambridge, 1995. https://doi.org/10.1017/CBO9780511530043
    [2] S. B. Hsu, K. C. Chen, Ordinary differential equations with applications, Series on Applied Mathematics, Vol 23, World Scientific Press, 2022, 3rd Edition. https://doi.org/10.1142/8744
    [3] W. A. Coppel, Stability and asymptotic behaivor of differential equations, Health. Math. Monograph, 1965.
    [4] P. Lancaster, M. Tismenetsky, The Theory of Matrices-second edition: With Applications, Academic Press, 1985.
    [5] Z. Chen, S. B. Hsu, Y. T. Yang, The continuous Morbidostat : a chemostat controlled drug application to select for drug resistance mutants, Commun. Pur. Appl. Anal., 19 2020,203–220. https://doi.org/10.3934/cpaa.2020011 doi: 10.3934/cpaa.2020011
    [6] Z. Chen, S. B. Hsu, Y. T. Yang, The Morbidostat: A Bio-reactor That Promotes Selection for Drug Resistance in Bacteria, SIAM J. Appl. Math., 77 (2017), 470–499. https://doi.org/10.1137/16M105695X doi: 10.1137/16M105695X
    [7] H. L. Smith, P. Waltman, Perturbation of a Globally Stable Steady State, Proceedings of the American Mathematical Society, 127 (1999), 447–453. https://doi.org/10.1090/S0002-9939-99-04768-1 doi: 10.1090/S0002-9939-99-04768-1
    [8] M. Barber, Infection by penicillin resistant Staphylococci, Lancet, 2 (1948), 641–644. https://doi.org/10.1016/S0140-6736(48)92166-7 doi: 10.1016/S0140-6736(48)92166-7
    [9] S. B. Levy, B. Marshall, Antibacterial resistance worldwide: causes, challenges and responses, Nat. Med., 10 (2004), s122–s129. https://doi.org/10.1038/nm1145 doi: 10.1038/nm1145
    [10] E. Toprak, A. Veres, S. Yildiz, J. M. Pedraza, R. Chait, J. Paulsson, et al., Building a morbidostat: an automated continuous-culturre device for studying bacterial drug resistance under dynamically sustained drug inhibition, Nat. protoc., 8 (2013), 555–567. https://doi.org/10.1038/nprot.2013.021 doi: 10.1038/nprot.2013.021
    [11] E. Toprak, A. Veres, J. B. Michel, R. Chait, D. L. Hartl, R. Kishony, Evolutionary paths to antibiotic resistance under dynamically sustained drug selection, Nat. Genet., 44 (2012), 101–105.
  • Reader Comments
  • © 2023 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(1847) PDF downloads(97) Cited by(0)

Figures and Tables

Figures(12)

Other Articles By Authors

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog